載入...
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial
BACKGROUND: The use of electroconvulsive therapy (ECT) is limited by concerns about its cognitive adverse effects. Preliminary evidence suggests that administering the glutamate antagonist ketamine with ECT might alleviate cognitive adverse effects and accelerate symptomatic improvement; we tested t...
Na minha lista:
| 發表在: | Lancet Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406618/ https://ncbi.nlm.nih.gov/pubmed/28359862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2215-0366(17)30077-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|